ARCHIVES

In Brief: Durant To Leave Alabama, Will Become President, Chief Executive Officer At Fox Chase Cancer Center

This article is from The Cancer Letter archive.

Vol. 08 No. 36 | September 17, 1982

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 3 Issue 1, Winter 1989

January 13, 1989

Genitope Therapy In Phase III Trials For Low-Grade B-Cell Non-Hodgkin’s.

October 26, 2001

Reversing Policy On Cancer Control Research, New Center Guidelines Top Accomplishments, Terry Believes

August 21, 1981

DCE Board Approves Recompetition Concepts

March 18, 1988

Industry Groups Lobby for Lower Standards for FDA Approval

November 18, 2011

Also in this 8-page issue: FISH assay predicts survival on Iressa, Univ. of Colorado Cancer Center study finds.

May 6, 2005